Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
169.6 USD | -0.26% | -3.45% | +36.74% |
Apr. 16 | Stifel Adjusts Price Target on Krystal Biotech to $204 From $178, Maintains Buy Rating | MT |
Mar. 12 | Krystal Biotech Insider Sold Shares Worth $8,547,719, According to a Recent SEC Filing | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Dividend / Share (DPS) - Change in analysts' estimates
Cash or Net Debt - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- KRYS Stock
- Revisions Krystal Biotech, Inc.